Tackling climate change remains one of the defining challenges of our times, here in Europe, as well as all around the world. Substantial investment is needed for the European Union to lead the ongoing technological transition towards a more efficient and competitive economy, to reduce dependency on fossil fuels and ensure security and strategic autonomy, and to adapt to the increasingly costly impact of rising temperatures and extreme weather events. Green investment is the smartest decision we can make for...

The drumbeat of new tariffs continues. President Trump has announced a 25% tariff on imported medium- and heavy-duty trucks, effective November 1, 2025. This comes after a federal investigation into truck imports and is designed to protect U.S. manufacturers such as PACCAR, the parent company of Peterbilt and Kenworth, and Ford. Most U.S. truck imports come from Mexico, which exports nearly all its heavy-duty trucks to the U.S. While USMCA allows tariff-free trade for vehicles meeting local content rules, non-qualifying...

The securitized data-center market is entering a critical phase, with maturity schedules and note rates signaling both opportunity and refinancing risk amidst heavy borrower demand. Nearly $6.5 billion in CMBS loans come due between 2026 and 2028, led by a $3.7 billion tranche maturing in 2027 at a median note rate of 9.31%—mostly floating-rate debt that was originated at a much lower original coupon. That figure stands out against the 5.86% median for 2026 maturities and 6.53% for 2028,...

EIB Group President Nadia Calviño delivered the closing remarks of the panel discussion on the State of World on 9 October, during the Global Gateway Forum 2025 in Brussels. Thank you very much. Indeed, I was listening to this very interesting panel, and I am absolutely delighted to have the opportunity to close this very interesting, very insightful exchange with very interesting metaphors to try to describe what we are living these days. This new global order that is in the making. We are at a historical...

• CTIBIOTECH has been selected by SATT AxLR and CILCARE to develop the OrgaEar project, a disruptive innovation in hearing disorders research. • Hearing disorders are a growing public health crisis. The development of innovative therapeutic solutions is an urgent strategic priority. • Facilitating a highly advanced non-animal New Approach Methods NAMs alternative in the hearing disorders sector, CTIBIOTECH strengthens its position at the forefront of a cell-based bioassay market estimated at 28 billion euros by 2028, CAGR > 7%). Montpellier and Lyon, France – October 9, 2025: Cilcare is...

European Commission unveils “Apply AI” strategy to make Europe a global leader On Wednesday (8 October), the European Commission shared its €1 billion plan to boost the use in key industries, create leading European AI businesses, and reduce the EU’s dependency on American and Chinese technologies. The strategy aims to speed up the use of artificial intelligence across Europe’s economy, especially among small and medium-sized businesses (SMEs) and in the eleven sectors essential to European competitiveness identified by Mario Draghi, former European Central...

Key insights • You’re focused on growing your business — increasing revenue, expanding your team, and serving more customers. But growth alone doesn’t guarantee future success. Enhancing business value is essential. • Profitability is a strategic decision driven by effective leadership, operational excellence, and the ability to maintain steady cash flow, all of which enhance business value. • If you’re not intentionally building business value, you could be leaving opportunity on the table when it comes time to sell, transition, or scale. •...

By: Dennis J. Butler A granted U.S. patent can be challenged through various administrative procedures under U.S. patent law at the U.S. Patent and Trademark Office (“USPTO”), which are designed to provide a faster, cheaper alternative to challenging the patent in a federal court litigation. The most common administrative procedures include ex parte reexamination, inter partes review and post grant review. 1. Ex Parte Reexamination Ex parte reexamination allows a third party or the patent owner themselves to request that the USPTO reexamine a granted U.S. patent. Ex parte reexamination is...